NLRP3 and COVID-19: MCC950 treatment also alleviates excessive lung inflammation and COVID-19–like pathology in adeno-associated virus (AAV)-hACE2 transgenic mice, indicating that the NLRP3 inflammasome induces excessive inflammatory responses during SARS-CoV-2 infection [65].